Monthwise SARS CoV-2 mutation statistics
| Position | Mutation | Clade |
|---|---|---|
| 1731 | nsp3:C1731F; | CL-1b;CL-3e; |
| 1731 | nsp3:C1731Y; | CL-3b; |
| 1852 | nsp3:C1852-; | CL-3e; |
| 1852 | nsp3:C1852Y; | CL-3e;CL-5; |
| 1876 | nsp3:C1876-; | CL-1b;CL-3b; |
| 285 | nsp3:C285S; | CL-3f; |
| 285 | nsp3:C285Y; | CL-3d; |
| 296 | nsp3:C296-; | CL-3e;CL-3f; |
| 296 | nsp3:C296F; | CL-1a_3e;CL-3e; |
| 296 | nsp3:C296R; | CL-3b; |
| 296 | nsp3:C296S; | CL-3f; |
| 347 | nsp3:C347-; | CL-3e;CL-3f; |
| 347 | nsp3:C347F; | CL-1a_3d_3e; |
| 417 | nsp3:C417Y; | CL-1a_3d;CL-3e;CL-3f; |
| 531 | nsp3:C531-; | CL-3b; |
| 55 | nsp3:C55-; | CL-3e; |
| 55 | nsp3:C55G; | CL-3e; |
| 55 | nsp3:C55R; | CL-3d;CL-3f; |
| 55 | nsp3:C55S; | CL-3b; |
| 55 | nsp3:C55Y; | CL-3b;CL-3e; |
| 574 | nsp3:C574S; | CL-3d; |
| 574 | nsp3:C574Y; | CL-3e; |
| 856 | nsp3:C856-; | CL-3b; |
| 926 | nsp3:C926-; | CL-3e; |
| 926 | nsp3:C926Y; | CL-3c; |
| 934 | nsp3:C934-; | CL-3c;CL-3e; |
| 934 | nsp3:C934V; | CL-3b; |
| 937 | nsp3:C937-; | CL-3e; |
| 1031 | nsp3:D1031E; | CL-3f; |
| 1031 | nsp3:D1031N; | CL-3f; |
| 1075 | nsp3:D1075-; | CL-3e; |
| 1075 | nsp3:D1075N; | CL-3c; |
| 1079 | nsp3:D1079Y; | CL-3f; |
| 1085 | nsp3:D1085-; | CL-3e; |
| 1085 | nsp3:D1085A; | CL-3d; |
| 1085 | nsp3:D1085N; | CL-3e;CL-3f; |
| 1085 | nsp3:D1085Y; | CL-3c;CL-3e;CL-3f;CL-5; |
| 10 | nsp3:D10V; | CL-3e; |
| 110 | nsp3:D110-; | CL-1b;CL-3b;CL-3c;CL-3e;CL-3f; |
| 1108 | nsp3:D1108-; | CL-3e; |
| 1108 | nsp3:D1108G; | CL-2;CL-3b; |
| 1108 | nsp3:D1108H; | CL-3e; |
| 110 | nsp3:D110G; | CL-3d; |
| 110 | nsp3:D110N; | CL-3b;CL-3e; |
| 112 | nsp3:D112-; | CL-1a_3e;CL-3b;CL-3c;CL-3e; |
| 1121 | nsp3:D1121-; | CL-3b;CL-3e;CL-3f; |
| 1121 | nsp3:D1121G; | CL-1a;CL-2;CL-3b;CL-3c;CL-3e;CL-5; |
| 1121 | nsp3:D1121Y; | CL-5; |
| 1122 | nsp3:D1122Y; | CL-3c;CL-3e; |
| 112 | nsp3:D112G; | CL-3d;CL-3e; |
Page 255 of 409
Tutorial Link
For More Web Development Tutorials Visit: AllPHPTricks.com